GetTopicDetailResponse(id=413159126ed, topicName=無肝纖維化, introduction=無肝纖維化, content=null, image=null, comments=0, allHits=224, url=https://h5.medsci.cn/topic?id=59126, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=64463, tagList=[TagDto(tagId=64463, tagName=無肝纖維化)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2268201, encodeId=b4a4226820189, content=<a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a> <a href='/topic/show?id=413159126ed' target=_blank style='color:#2F92EE;'>#無肝纖維化#</a> <a href='/topic/show?id=ab90126835d7' target=_blank style='color:#2F92EE;'>#EASL2025#</a>, objectTitle=EASL2025丨“揚(yáng)帆”項(xiàng)目：合并MASLD顯著提升無肝纖維化慢乙肝患者的抗病毒治療應(yīng)答, objectType=article, longId=874290, objectId=b66a8e42902d, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240609/1717862725134_92910.png, objectUrl=/article/show_article.do?id=b66a8e42902d, replyNumber=0, likeNumber=30, createdTime=2025-06-06, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=b66a8e42902d, moduleTitle=EASL2025丨“揚(yáng)帆”項(xiàng)目：合并MASLD顯著提升無肝纖維化慢乙肝患者的抗病毒治療應(yīng)答, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=b66a8e42902d)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯話題小助手
2020-05-29
